Back to Market Feed

SKYRIZI 360 MG/2.4 ML ON-BODY

Risankizumab-rzaa

$9679.4900per ML

Manufacturer

NDC

00074107001

Classification

Brand

Dosage Form

KIT

Route

INTRAVENOUS

Last Updated

1/2/2026

Approval Type

Biologic (BLA)

FDA Application

On Market Since

6/16/2022

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+6.7%

1Y

+6.7%

3Y

N/A

5Y

N/A

All

+13.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

No related drugs found.